Peripartum DepressionNCT03282448
Video-based Family Therapy for Peripartum Depression in Home Visited Mothers
A study testing family therapy in people with Peripartum Depression, run by Fallon P. Cluxton-Keller at 2 sites in United States.
Trial summary
This pilot study will explore the feasibility and acceptability of implementing a family-based treatment, using HIPAA-compliant video-based communication technology, for adolescents (pregnant and post-delivery) with peripartum depressive symptoms within the context of home visiting. Read more about this study
- Who is it for?
- Ages 13 to 25 years
- Conditions the study is for
- Peripartum Depression
- What is being tested?
- family therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 26 participants
- Where
- 2 sitesUnited States
- Study dates
- 26 May 2017to 13 Jun 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 25 years
- All sexes
- No healthy volunteers
- Child, Adult
Home Visitor Inclusion Criteria:
- Willingness to participate in the study;
- Intention to remain in current job for at least 12 months; and
- Fluency in English: The training, treatment model, implementation meetings, and supervision sessions will be carried out in English.
Family Inclusion Criteria:
- Adolescent mothers, ages 13-25, in the first trimester of pregnancy through eighteen months postpartum;
- Adolescent mothers with Edinburgh Postnatal Depression Scale scores of ≥8;
- At least one of the adolescent mother's family members ("family member" is defined as a person she is biologically related to, or significant close others/partners with whom she is not biologically related) must be willing and available to participate in eight of the 10 video-based family therapy sessions;
- Fluency in English: The treatment will be carried out in English; and
- Consistent internet access (i.e., subscribe to an internet service provider and do not experience weekly disruptions in service) on a cell phone, tablet, or computer equipped with a camera and microphone.
Family Exclusion Criteria:
Adolescent mothers with
- A current positive screen for problem alcohol use on the CAGE or TWEAK;
- A current positive screen on the drug abuse items on the home visiting interview;
- A current positive screen for domestic violence on the Relationship Assessment Tool;
- Current hallucinations and/or delusions;
- Current homicidal ideation;
- Current suicidal ideation;
- Current severe major depressive episode as measured by the SCID-V Depression Module for those over age 18, or NIMH DISC-Y \& DISC-P Mood Module for those under age 18; and/or
- Current self-injurious behavior (e.g., cutting arms on a weekly basis). Families with
- Current Child Protection Service involvement;
- Current family therapy service involvement; and/or
- Current or previous Dialectical Behavior Therapy (DBT) treatment.
Trial locations and contacts
2 sites in 1 country.
United States2 sites
TLC Family Resource Center
Claremont, New Hampshire, 03743
The Family Resource Center at Gorham
Gorham, New Hampshire, 03581
About this study
Official title: Integrated Video-based Family Therapy for Peripartum Depression in Home Visited Mothers: A Pilot Study
This pilot study will explore the feasibility and acceptability of implementing a family-based treatment, using HIPAA-compliant video-based communication technology, for adolescents (pregnant and post-delivery) with peripartum depressive symptoms within the context of home visiting.
Read the detailed description
The purpose of the pilot study is to partner with two Federal Maternal, Infant and Early Childhood Home Visiting (HV) Program sites to implement a family-based treatment for depression, using HIPAA-compliant video-based communication technology, in adolescent mothers (pregnant and post-delivery). This implementation-effectiveness hybrid trial includes depressed adolescent mothers and their adult family members.
It has three aims:
- Explore the feasibility of integrating the treatment model into two Federal HV Program sites in New Hampshire.
- Test the acceptability of the treatment model among depressed adolescent mothers and their families.
- Explore preliminary impacts of the treatment on maternal depressive symptoms and parenting attitudes, family emotion regulation, and family functioning at two months post-intervention.
- Conditions
- Peripartum Depression
- Being tested
- family therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
family therapyBehavioural
The family-based intervention is informed by Dialectical Behavior Therapy Skills Training for Adolescents (Rathus \& Miller, 2014).
| Study group | Role | What they receive |
|---|---|---|
| Family therapy | Experimental | Adolescent mothers and their family members will receive a total of 10 weekly, 30-minute, video-based family therapy sessions. Receives: Behavioral: family therapy |
| Historical comparison group | No intervention | The Edinburgh Postnatal Depression Scale scores of adolescent mothers in the intervention group will be compared to those of adolescent mothers, who were previously enrolled in the home visiting programs, at the same time points. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maternal depressive symptoms
Depressive symptoms will be measured using the Beck Depression Inventory (BDI-II; Beck, Steer, \& Brown, 1996)
Measured: 5 months
Secondary outcomes (5)
Therapist-family working alliance
Clinician rated, and maternal report and family member report.
Measured: 2.5 months
Family Satisfaction
Maternal report and family member report.
Measured: 2.5 months
Parenting attitudes
A reliable and valid self-report measure will be completed by mothers.
Measured: 5 months
Emotion regulation
A reliable and valid self-report measure will be completed by mothers and their family members.
Measured: 5 months
Family functioning
A reliable and valid self-report measure will be completed by mothers and their family members.
Measured: 5 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2017
- Study start26 May 2017
- Primary completion13 Jun 2018
- Study completion13 Jun 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Peripartum DepressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fallon P. Cluxton-Keller
- Sponsor type
- University, hospital or other
- Collaborators
- National Center for Advancing Translational Sciences (NCATS), Dartmouth-Hitchcock Medical Center
- Responsible party
- Sponsor-investigator, Fallon P. Cluxton-Keller, Dartmouth-Hitchcock Medical Center
- Investigators
- Fallon P. Cluxton-Keller, Ph.D., Principal investigator, Dartmouth CollegeCraig L. Donnelly, M.D., Principal investigator, Dartmouth CollegeMartha L. Bruce, Ph.D., Study chair, Dartmouth College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03282448
- Sponsor's protocol ID
- 29987
- Other IDs
- UL1TR001086
- Status last verified
- Jun 2018
- First submitted
- 12 Sep 2017
- Last updated
- 19 Jun 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Cluxton-Keller F, Donnelly CL, Williams M, Buteau J, Stolte P, Monroe-Cassel M, Bruce ML. An implementation-effectiveness hybrid trial of video-based family therapy for peripartum depression in home visited mothers: a protocol for a pilot trial. Pilot Feasibility Stud. 2017 Nov 13;3:55. doi: 10.1186/s40814-017-0203-2. eCollection 2017.
PubMed 29158913
Study at a glance
From the registry record, last updated by the sponsor on 19 Jun 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Integrated Video-based Family Therapy for Peripartum Depression in Home Visited Mothers: A Pilot Study
- ClinicalTrials.gov ID
- NCT03282448
- Acronym / sponsor ID
- 29987
- Conditions
- Peripartum Depression
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Fallon P. Cluxton-KellerUniversity, hospital or other
- Collaborators
- National Center for Advancing Translational Sciences (NCATS), Dartmouth-Hitchcock Medical Center
- Study start
- 26 May 2017 (actual)
- Primary completion
- 13 Jun 2018 (actual)
- Study completion
- 13 Jun 2018 (actual)
- First posted
- 14 Sep 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot study will explore the feasibility and acceptability of implementing a family-based treatment, using HIPAA-compliant video-based communication technology, for adolescents (pregnant and post-delivery) with peripartum depressive symptoms within the context of home visiting.
Detailed description
The purpose of the pilot study is to partner with two Federal Maternal, Infant and Early Childhood Home Visiting (HV) Program sites to implement a family-based treatment for depression, using HIPAA-compliant video-based communication technology, in adolescent mothers (pregnant and post-delivery). This implementation-effectiveness hybrid trial includes depressed adolescent mothers and their adult family members.
It has three aims:
- Explore the feasibility of integrating the treatment model into two Federal HV Program sites in New Hampshire.
- Test the acceptability of the treatment model among depressed adolescent mothers and their families.
- Explore preliminary impacts of the treatment on maternal depressive symptoms and parenting attitudes, family emotion regulation, and family functioning at two months post-intervention.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Family therapy | Experimental | Behavioral: family therapyAdolescent mothers and their family members will receive a total of 10 weekly, 30-minute, video-based family therapy sessions. |
| Historical comparison group | No intervention | –The Edinburgh Postnatal Depression Scale scores of adolescent mothers in the intervention group will be compared to those of adolescent mothers, who were previously enrolled in the home visiting programs, at the same time points. |
Who may qualify
- Ages
- 13 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| family therapyThe family-based intervention is informed by Dialectical Behavior Therapy Skills Training for Adolescents (Rathus \& Miller, 2014). | Behavioural | Family therapy |
Primary outcome
Maternal depressive symptoms
Time frame: 5 months
Depressive symptoms will be measured using the Beck Depression Inventory (BDI-II; Beck, Steer, \& Brown, 1996)
5 secondary outcomes
Therapist-family working alliance
Time frame: 2.5 months
Family Satisfaction
Time frame: 2.5 months
Parenting attitudes
Time frame: 5 months
Emotion regulation
Time frame: 5 months
Family functioning
Time frame: 5 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jun 2018.
- Derived from this study: PubMed 29158913Cluxton-Keller F, Donnelly CL, Williams M, Buteau J, Stolte P, Monroe-Cassel M, Bruce ML. An implementation-effectiveness hybrid trial of video-based family therapy for peripartum depression in home visited mothers: a protocol for a pilot trial. Pilot Feasibility Stud. 2017 Nov 13;3:55. doi: 10.1186/s40814-017-0203-2. eCollection 2017.
Related trials for Peripartum Depression
Recruiting
Treatment With Repetitive Transcranial Magnetic Stimulation in Peripartal Depression
Depression During Pregnancy, Postpartum Depression (PPD)
RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Depression, Postpartum, Postpartum Depression (PPD)
Not yet recruiting
Effect of Peripartum 40 Hz Audiovisual Stimulation on Postpartum Depression in Women Undergoing Elective Cesarean Section: A Randomized Clinical Trial
Depression, Postpartum
RecruitingPhase 2
Sleep to Reduce Incident Depression Effectively in Peripartum
Insomnia, Depression
Recruiting
New Cognitive Treatment for Peripartum Depression
Postnatal Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fallon P. Cluxton-Keller, Ph.D. principal investigator
Dartmouth College
Craig L. Donnelly, M.D. principal investigator
Dartmouth College
Martha L. Bruce, Ph.D. study chair
Dartmouth College
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing family therapy in people with Peripartum Depression, run by Fallon P. Cluxton-Keller at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maternal depressive symptoms (time frame: 5 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03282448, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2018.